Profit

NSE Symbol: | BSE Code: | ISIN: | Sector:

  • Add to Portfolio
  • Add to Watchlist
  • Add to Alert
  • Add to Message
Add to Portfolio
NSE
356.25
Change Change %
-12.80 -3.47%

Updated:15 Oct, 2019, 15:59 PM IST

BSE
355.00
Change Change %
-9.15 -2.51%

Updated:15 Oct, 2019, 16:01 PM IST

Astec Lifesciences's Financial Summary

View last 5 years Financial Summary

Parameter MAR'18
(₹ Cr.)
MAR'17
(₹ Cr.)
Change %
Net Profit Before Taxes 55.68 28.63 94.49%
Adjustments for Expenses & Provisions 17.94 34.67 -48.26%
Adjustments for Liabilities & Assets 6.38 -37.49 117.03%
Cash Flow from operating activities 64.69 19.16 237.58%
Cash Flow from investing activities -48.94 -17.70 -176.52%
Cash Flow from financing activities -18.24 -0.94 -1850.98%
Effect of exchange fluctuation on translation reserve 0.00 0.00 0.00%
Net increase/(decrease) in cash and cash equivalents -2.49 0.53 -571.89%
Opening Cash & Cash Equivalents 2.74 2.21 23.92%
Cash & Cash Equivalent on Amalgamation / Take over / Merger 0.00 0.00 0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations 0.00 0.00 0.00%
Translation adjustment on reserves / op cash balalces frgn subsidiaries 0.00 0.00 0.00%
Effect of Foreign Exchange Fluctuations 0.00 0.00 0.00%
Closing Cash & Cash Equivalent 0.24 2.74 -91.10%
Top